Literature DB >> 7295509

Corynebacterium parvum stimulation of adherent and non-adherent cytotoxic cells in mice.

Z M Hassan, R C Rees, C W Potter.   

Abstract

Two naturally occurring cytotoxic cell populations have been identified in the peritoneal cavity of mice inoculated with C. parvum (CP), and are distinguishable on the basis of target-cell reactivity and intrinsic properties. The first effector cell was non-adherent to nylon wool and glass and non-phagocytic. These cells were selectively cytotoxic to the NK-sensitive target cell line K562, and present in the peritoneal cavity of mice 2 days after treatment with 700 micrograms of CP. The second cytotoxic effector cell was adherent to nylon wool and glass, and killed EL4 lymphoma cells derived from in vivo tumour transplants; these target cells are susceptible to phagocytic cell killing, but not NK-cell cytotoxicity in short-term (4h) assays. The adherent cytotoxic population of effector cells was present 4 days after inoculation of CP. In vivo studies showed that CP injected i.p. induced resistance to i.p. challenge with lymphoma EL4 cells, but no resistance was evident when the challenge dose was administered s.c. Adoptive-transfer studies showed that the effector cell type responsible for inhibiting tumour growth was nylon-wool adherent, probably CP-activated macrophages.

Entities:  

Mesh:

Year:  1981        PMID: 7295509      PMCID: PMC2010792          DOI: 10.1038/bjc.1981.222

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  26 in total

1.  Subpopulations of multiparous rat lymph-node cells cytotoxic for rat tumour cells and capable of suppressing cytotoxicity in vitro.

Authors:  R C Rees; J Bray; R A Robins; R W Baldwin
Journal:  Int J Cancer       Date:  1975-05-15       Impact factor: 7.396

Review 2.  Antitumor activity of Corynebacterium parvum.

Authors:  L Milas; M T Scott
Journal:  Adv Cancer Res       Date:  1978       Impact factor: 6.242

3.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

4.  Immunotherapy of cancer: regression of intradermal tumors and prevention of growth of lymph node metastases after intralesional injection of living Mycobacterium bovis.

Authors:  B Zbar; I D Bernstein; G L Bartlett; M G Hanna; H J Rapp
Journal:  J Natl Cancer Inst       Date:  1972-07       Impact factor: 13.506

5.  Antitumour effects of Corynebacterium parvum in mice.

Authors:  J E Castro
Journal:  Eur J Cancer       Date:  1974-02       Impact factor: 9.162

6.  Introduction of "natural" killer' cells by BCG.

Authors:  S A Wolfe; D E Tracey; C S Henney
Journal:  Nature       Date:  1976-08-12       Impact factor: 49.962

7.  "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype.

Authors:  R Kiessling; E Klein; H Wigzell
Journal:  Eur J Immunol       Date:  1975-02       Impact factor: 5.532

8.  Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity.

Authors:  R B Herberman; M E Nunn; D H Lavrin
Journal:  Int J Cancer       Date:  1975-08-15       Impact factor: 7.396

9.  Natural cell-mediated cytotoxicity in rats. II. In vivo augmentation of NK-cell activity.

Authors:  J R Oehler; L R Lindsay; M E Nunn; H T Holden; R B Herberman
Journal:  Int J Cancer       Date:  1978-02-15       Impact factor: 7.396

10.  Factors affecting stimulation of natural cytotoxicity to a rat lymphoma by Corynebacterium parvum.

Authors:  J P Flexman; G R Shellam
Journal:  Br J Cancer       Date:  1980-07       Impact factor: 7.640

View more
  1 in total

1.  Large agranular lymphocytes: early non-specific effector cells in allograft rejection in the mouse.

Authors:  C D Gregory; M E Atkinson
Journal:  Immunology       Date:  1984-10       Impact factor: 7.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.